Live Breaking News & Updates on Heena Dhedhi

Stay updated with breaking news from Heena dhedhi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lupin : May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules

Mumbai, Naples, May 16, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its Abbreviated. ....

South Africa , United States , Asia Pacific , Heena Dhedhi , Corporate Communications , Novartis Pharmaceuticals Corporation , Biotechnology Pharmaceuticals , Lupin Limited , Drug Administration , United States Food , Abbreviated New Drug Application , Midostaurin Capsules , Novartis Pharmaceuticals , Latin America , Middle East , Great Place , General Manager ,

Lupin : May 6, 2024 Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP

Mumbai, Naples, May 06, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its Abbreviated. ....

United States , South Africa , Heena Dhedhi , Asia Pacific , Lupin Limited , Biotechnology Pharmaceuticals , Sandoz Inc , Drug Administration , Corporate Communications , United States Food , Abbreviated New Drug Application , Travoprost Ophthalmic Solution , Ionic Buffered Solution , Ophthalmic Solution , Latin America , Middle East , Great Place , General Manager ,

Lupin : May 3, 2024 Lupin Launches Rymti® Biosimilar Etanercept in Canada

Rymti® is Lupin s first biosimilar launch in Canada

Rymti® is approved for all indications of the reference product Enbrel®

. ....

South Africa , Heena Dhedhi , Vinita Gupta , Michel Robidoux , Asia Pacific , Cyrus Karkaria , Corporate Communications , Biotechnology Pharmaceuticals , Lupin Limited , Health Canada , Sandoz Canada , Chief Executive Officer , President Biotechnology , General Manager , Tumor Necrosis Factor , Latin America , Middle East , Great Place ,

Lupin : April 25, 2024 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%

Mumbai, Naples, April 25, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. ....

United States , South Africa , Heena Dhedhi , Asia Pacific , Bausch Lomb Inc , Lupin Limited , Corporate Communications , Drug Administration , Biotechnology Pharmaceuticals , United States Food , Abbreviated New Drug Application , Loteprednol Etabonate Ophthalmic Suspension , Ophthalmic Suspension , Etabonate Ophthalmic Suspension , Latin America , Middle East , Great Place , General Manager ,

Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States

Mumbai, Naples, April 20, 2024: Global pharma major Lupin Limited today announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received. ....

South Africa , United States , Asia Pacific , Heena Dhedhi , Biotechnology Pharmaceuticals , Lupin Limited , Astellas Pharma Global Development Inc , Corporate Communications , Astellas Pharma Inc , Drug Administration , Mirabegron Extended Release Tablets , United States Food , Extended Release Tablets , Astellas Pharma Global Development , Latin America , Middle East , Great Place , General Manager , Safe Harbor , Astellas Pharma ,